BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20472604)

  • 1. The impact of information order on intentions to undergo predictive genetic testing: an experimental study.
    Morrison V; Henderson BJ; Taylor C; A'Ch Dafydd N; Unwin A
    J Health Psychol; 2010 Oct; 15(7):1082-92. PubMed ID: 20472604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study.
    Kasparian NA; Meiser B; Butow PN; Soames Job RF; Mann GJ
    Psychooncology; 2007 Jan; 16(1):69-78. PubMed ID: 16874747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
    Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
    Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intention to pursue genetic testing for breast cancer among women due for screening mammography.
    Gwyn K; Vernon SW; Conoley PM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):96-102. PubMed ID: 12582018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.
    Bruno M; Digennaro M; Tommasi S; Stea B; Danese T; Schittulli F; Paradiso A
    Eur J Cancer Care (Engl); 2010 May; 19(3):360-8. PubMed ID: 19912305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing intention to obtain a genetic test for a hereditary disease in an affected group and in the general public.
    Nordin K; Björk J; Berglund G
    Prev Med; 2004 Dec; 39(6):1107-14. PubMed ID: 15539044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intention to learn results of genetic testing for hereditary colon cancer.
    Vernon SW; Gritz ER; Peterson SK; Perz CA; Marani S; Amos CI; Baile WF
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):353-60. PubMed ID: 10207640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Information seeking and intentions to have genetic testing for hereditary cancers in rural and Appalachian Kentuckians.
    Kelly KM; Andrews JE; Case DO; Allard SL; Johnson JD
    J Rural Health; 2007; 23(2):166-72. PubMed ID: 17397374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes toward colon cancer gene testing: factors predicting test uptake.
    Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility intentions following testing for a BRCA1 gene mutation.
    Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intention to communicate BRCA1/BRCA2 genetic test results to the family.
    Barsevick AM; Montgomery SV; Ruth K; Ross EA; Egleston BL; Bingler R; Malick J; Miller SM; Cescon TP; Daly MB
    J Fam Psychol; 2008 Apr; 22(2):303-12. PubMed ID: 18410217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
    Struewing JP; Lerman C; Kase RG; Giambarresi TR; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):169-73. PubMed ID: 7742725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health motivation and emotional vigilance in genetic testing for prostate cancer risk.
    Li Y; Doukas DJ
    Clin Genet; 2004 Dec; 66(6):512-6. PubMed ID: 15521978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing intention to obtain a genetic test for colon cancer risk: a population-based study.
    Bunn JY; Bosompra K; Ashikaga T; Flynn BS; Worden JK
    Prev Med; 2002 Jun; 34(6):567-77. PubMed ID: 12052015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of interest in direct-to-consumer genetic testing.
    Sweeny K; Legg AM
    Psychol Health; 2011 Oct; 26(10):1259-72. PubMed ID: 21500101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of genetic risk information in families with a high density of bipolar disorder: an exploratory study.
    Meiser B; Mitchell PB; McGirr H; Van Herten M; Schofield PR
    Soc Sci Med; 2005 Jan; 60(1):109-18. PubMed ID: 15482871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spiritual faith and genetic testing decisions among high-risk breast cancer probands.
    Schwartz MD; Hughes C; Roth J; Main D; Peshkin BN; Isaacs C; Kavanagh C; Lerman C
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):381-5. PubMed ID: 10794482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse or physician: whose recommendation influences the decision to take genetic tests more?
    Barnoy S; Levy O; Bar-Tal Y
    J Adv Nurs; 2010 Apr; 66(4):806-13. PubMed ID: 20423368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.